Related Experiment Video
Updated: Aug 14, 2026
04:28
Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
Summary
The number of certified medical oncologists is projected to meet clinical demand by 1990, but a shortage of academic oncologists may persist. Ongoing assessment is needed to prevent overproduction and ensure quality care.
Area of Science:
- Medical Oncology
- Healthcare Workforce Analysis
Background:
- Growing number of trained medical oncologists raises concerns about potential overproduction.
- Current medical oncology training programs have a significant number of trainees across all years.
Purpose of the Study:
- To assess the projected supply of certified medical oncologists.
- To identify potential shortages or surpluses in clinical and academic oncology roles.
- To inform strategies for maintaining quality and adequate supply in oncology.
Main Methods:
- Survey of 154 medical oncology training programs to count current trainees.
- Analysis of certification examination data and pass rates.
- Projection of certified medical oncologist numbers through 1989.
Main Results:
- As of the survey, 767 trainees were enrolled in 154 programs.
- By 1989, the number of certified medical oncologists is projected to reach 4,779.
- A deficiency in clinical medical oncologists is not anticipated by 1990, but a shortage of academic oncologists is indicated.
Conclusions:
- The supply of clinical medical oncologists is expected to meet demand by 1990.
- A potential shortage of academic oncologists requires attention.
- Continuous assessment of workforce needs is crucial to avoid overproduction and ensure quality in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...